Profil
Sanjaya Singh is the founder of Third Arc Bio, Inc., founded in 2022, serving as Chief Scientific Officer.
Dr. Singh is also the founder of Aliada Therapeutics, Inc...
Dr. Singh is an Independent Non-Executive Director at Syngene International Ltd. since 2025.
Dr. Singh is a Venture Partner at Omega Fund Management LLC since 2023.
Dr. Singh was Director at Tanox, Inc. from 2000 to 2007.
Dr. Singh was Director & Vice President at C.H.
Boehringer Sohn AG & Co. KG from 2007 to 2016.
Dr. Singh was Vice President & Global Head at Janssen Pharmaceuticals, Inc. from 2016 to 2021.
Dr. Singh earned a doctorate from Banaras Hindu University.
Aktive Positionen von Sanjaya Singh
| Unternehmen | Position | Beginn |
|---|---|---|
| SYNGENE INTERNATIONAL LIMITED | Direktor/Vorstandsmitglied | 01.07.2025 |
Aliada Therapeutics, Inc.
Aliada Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that engages in CNS drug development works | Gründer | - |
Omega Fund Management LLC
Omega Fund Management LLC Investment ManagersFinance Omega Fund Management invests in private and public companies located in the United States and Europe. The firm focuses on sectors such as biotechnology, life sciences, healthcare and medical devices. It provides financing for seed, early, mid and later stage capital requirements. The firm also makes follow-on investments | Berater | 01.06.2023 |
Ehemalige bekannte Positionen von Sanjaya Singh
| Unternehmen | Position | Ende |
|---|---|---|
Janssen Pharmaceuticals, Inc.
Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets prescription drugs | Private Equity Investor | 31.12.2021 |
C.H. Boehringer Sohn AG & Co. KG
C.H. Boehringer Sohn AG & Co. KG Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops immuno-oncology therapies and veterinary drugs | Direktor/Vorstandsmitglied | 30.09.2016 |
Tanox, Inc.
Tanox, Inc. Pharmaceuticals: MajorHealth Technology Develops antibody and pharmaceutical solutions used for the treatment of allergic diseases | Direktor/Vorstandsmitglied | 31.05.2007 |
Ausbildung von Sanjaya Singh
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 7 |
|---|---|
Tanox, Inc.
Tanox, Inc. Pharmaceuticals: MajorHealth Technology Develops antibody and pharmaceutical solutions used for the treatment of allergic diseases | Health Technology |
Janssen Pharmaceuticals, Inc.
Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets prescription drugs | Health Technology |
C.H. Boehringer Sohn AG & Co. KG
C.H. Boehringer Sohn AG & Co. KG Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops immuno-oncology therapies and veterinary drugs | Health Technology |
Syngene International Ltd.
Syngene International Ltd. Miscellaneous Commercial ServicesCommercial Services Offers integrated discovery and development services | Commercial Services |
Banaras Hindu University
Banaras Hindu University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Omega Fund Management LLC
Omega Fund Management LLC Investment ManagersFinance Omega Fund Management invests in private and public companies located in the United States and Europe. The firm focuses on sectors such as biotechnology, life sciences, healthcare and medical devices. It provides financing for seed, early, mid and later stage capital requirements. The firm also makes follow-on investments | Finance |
Aliada Therapeutics, Inc.
Aliada Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that engages in CNS drug development works | Health Technology |
















